Hims & Hers Health, Inc. Overview
Industry: Household & Personal Products
Sector: Consumer Defensive
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California. Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescript Read MoreMavefund brings filings, fundamentals, valuation, price history and news for Hims & Hers Health, Inc. into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $753.2M (+38% YoY). Operating income was $26.7M (-115% YoY). Net loss was -$86.3M (from $42.5M).
What changed
- Revenue +38% YoY to $753.2M.
- Operating income -115% YoY to $26.7M.
- Net loss was -$86.3M (from $42.5M).
Guidance / outlook
For the third quarter 2026, we expect: • Revenue of $880 million to $900 million. • Adjusted EBITDA of $75 million to $95 million, reflecting an Adjusted EBITDA margin of 9% to 11%. For the full year 2026, we expect: • Revenue of $3.1 billion to $3.3 billion. • Adjusted EBITDA of $275 million to $325 million, reflecting an Adjusted EBITDA margin of 9% to 10%. The guidance provided above constitutes
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Securities Fraud Investigation Into Hims & Hers Health,
Headline from GlobeNewswire: Securities Fraud Investigation Into Hims & Hers Health,.
Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight?
Headline from Benzinga: Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight?
Securities Fraud Investigation Into Hims & Hers Health,
Headline from GlobeNewswire: Securities Fraud Investigation Into Hims & Hers Health,.
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?
Headline from Yahoo Finance: Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down
Headline from Yahoo Finance: Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down.
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?
Headline from Yahoo Finance: Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.